Bristol Myers Squibb
The Head of Radiopharmaceutical Diagnostic Development leads the strategic and operational execution of RayzeBio's diagnostic and companion imaging radiopharmaceutical portfolio, overseeing end‑to‑end development from candidate nomination through regulatory approval and global lifecycle management. This senior role partners with CMC, Quality, Regulatory Affairs, Clinical Development, Manufacturing, and Commercial teams to ensure timely, compliant delivery of imaging agents that support radioligand therapy programs worldwide.
Headquarters
Lawrence Township, New Jersey, United States
Company Size
10001+ employees
Founded
1887
Bristol Myers Squibb is a global biopharmaceutical company that discovers, develops, and delivers prescription medicines for serious diseases, with a focus on oncology, hematology, immunology, cardiovascular, neuroscience, and other therapeutic areas. The company operates in the pharmaceutical and biotechnology industry, serving patients worldwide through research, development, manufacturing, and commercialization of innovative therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Bristol Myers Squibb.
17% above the average for this role